SECURITIES AND EXCHANGE COMMISSION SUSPENDS TRADING IN SOUTHWESTERN MEDICAL SOLUTIONS, INC. DUE TO QUESTIONS ABOUT THE ACCURACY OF STATEMENTS MADE TO THE PUBLIC
sec.gov
U.S. SECURITES AND EXCHANGE COMMISSION
Washington, D.C.
SECURITIES EXCHANGE ACT OF 1934
RELEASE NO. 54419 / September 11, 2006
SECURITIES AND EXCHANGE COMMISSION SUSPENDS TRADING IN SOUTHWESTERN MEDICAL SOLUTIONS, INC. DUE TO QUESTIONS ABOUT THE ACCURACY OF STATEMENTS MADE TO THE PUBLIC
The Securities and Exchange Commission (Commission) announced the temporary suspension, pursuant to Section 12(k) of the Securities Exchange Act of 1934 (the Exchange Act), of trading in the securities of Southwestern Medical Solutions, Inc. (Southwestern), a Florida corporation based in Tampa, Florida, at 9:30 a.m. EST on September 11, 2006, and terminating at 11:59 EST on September 22, 2006.
The Commission temporarily suspended trading in the securities of Southwestern because of questions that have been raised about the accuracy and adequacy of publicly disseminated information concerning, among other things, the existence of applications for U.S. Food and Drug Administration approvals for its Labguard product, the existence of a patent and trademark, and the receipt of an order for the sale of several thousand units of Labguard. Southwestern, a non-reporting issuer, is quoted on the Pink Sheets under the ticker symbol SWNM.
The Commission cautions brokers, dealers, shareholders, and prospective purchasers that they should carefully consider the foregoing information along with all other currently available information and any information subsequently issued by the company.
Further, brokers and dealers should be alert to the fact that, pursuant to Rule 15c2-11 under the Exchange Act, at the termination of the trading suspension, no quotation may be entered unless and until they have strictly complied with all of the provisions of the rule. If any broker or dealer has any questions as to whether or not it has complied with the rule, it should not enter any quotation but immediately contact the staff in the Division of Market Regulation, Office of Interpretation and Guidance, at (202) 551-5760. If any broker or dealer is uncertain as to what is required by Rule 15c2-11, it should refrain from entering quotations relating to Southwestern’s securities until such time as it has familiarized itself with the rule and is certain that all of its provisions have been met. If any broker or dealer enters any quotation that is in violation of the rule, the Commission will consider the need for prompt enforcement action.
If any broker-dealer or other person has any information that may to relate to this matter, they should immediately contact Teresa Verges, Assistant Regional Director, at the Southeast Regional Office of the Securities and Exchange Commission, at (305) 982-6384.
sec.gov |
